Lopez-Iniesta M, Parkar S, Ramalho A, Lacerda R, Costa I, Zhao J
Int J Mol Sci. 2022; 23(24).
PMID: 36555484
PMC: 9779343.
DOI: 10.3390/ijms232415844.
Hong F, Castro M, Linse K
World J Clin Oncol. 2022; 13(5):323-338.
PMID: 35662982
PMC: 9153073.
DOI: 10.5306/wjco.v13.i5.323.
Merlin J, Rupasinghe H, Dellaire G, Murphy K
Oxid Med Cell Longev. 2021; 2021:9924328.
PMID: 34257824
PMC: 8257365.
DOI: 10.1155/2021/9924328.
Huang R, Zhou P
Signal Transduct Target Ther. 2021; 6(1):254.
PMID: 34238917
PMC: 8266832.
DOI: 10.1038/s41392-021-00648-7.
Kara A, Ozgur A, Nalbantoglu S, Karadag A
Mol Biol Rep. 2021; 48(4):3813-3825.
PMID: 33856604
DOI: 10.1007/s11033-021-06314-z.
Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis.
Awasthi S
Cancers (Basel). 2021; 13(2).
PMID: 33445456
PMC: 7827952.
DOI: 10.3390/cancers13020255.
OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
Kang X, Zhang J, Tang L, Huang L, Tong J, Fu Q
Chem Biol Drug Des. 2020; 96(2):790-800.
PMID: 32248621
PMC: 7496622.
DOI: 10.1111/cbdd.13688.
G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Amato R, Valenzuela M, Berardinelli F, Salvati E, Maresca C, Leone S
Genes (Basel). 2020; 11(3).
PMID: 32183119
PMC: 7140816.
DOI: 10.3390/genes11030304.
Identifying driver genes involving gene dysregulated expression, tissue-specific expression and gene-gene network.
Song J, Peng W, Wang F, Wang J
BMC Med Genomics. 2020; 12(Suppl 7):168.
PMID: 31888619
PMC: 6936147.
DOI: 10.1186/s12920-019-0619-z.
LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes.
Collier O, Stoven V, Vert J
PLoS Comput Biol. 2019; 15(9):e1007381.
PMID: 31568528
PMC: 6786659.
DOI: 10.1371/journal.pcbi.1007381.
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.
Demir S, Boldrin E, Sun Q, Hampp S, Tausch E, Eckert C
Haematologica. 2019; 105(1):170-181.
PMID: 31073076
PMC: 6939517.
DOI: 10.3324/haematol.2018.199364.
Aberrant DNA damage response and DNA repair pathway in high glucose conditions.
Zhong A, Chang M, Yu T, Gau R, Riley D, Chen Y
J Can Res Updates. 2018; 7(3):64-74.
PMID: 30498558
PMC: 6258084.
Systematic target function annotation of human transcription factors.
Li Y, Altman R
BMC Biol. 2018; 16(1):4.
PMID: 29325558
PMC: 5795274.
DOI: 10.1186/s12915-017-0469-0.
Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.
Bakrania A, Variya B, Patel S
Front Pharmacol. 2018; 8:930.
PMID: 29311933
PMC: 5742137.
DOI: 10.3389/fphar.2017.00930.
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.
Carr M, Jones S
Transl Cancer Res. 2017; 5(6):707-724.
PMID: 28690977
PMC: 5501481.
DOI: 10.21037/tcr.2016.11.75.
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.
Liu G, Pei F, Yang F, Li L, Amin A, Liu S
Int J Mol Sci. 2017; 18(2).
PMID: 28208579
PMC: 5343902.
DOI: 10.3390/ijms18020367.
Molecular markers of paragangliomas/pheochromocytomas.
Zhikrivetskaya S, Snezhkina A, Zaretsky A, Alekseev B, Pokrovsky A, Golovyuk A
Oncotarget. 2017; 8(15):25756-25782.
PMID: 28187001
PMC: 5421967.
DOI: 10.18632/oncotarget.15201.
Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records.
He K, Zhao Y, McPherson E, Li Q, Xia F, Weng C
PLoS One. 2016; 11(12):e0167847.
PMID: 27930734
PMC: 5145192.
DOI: 10.1371/journal.pone.0167847.
DNA repair, genome stability and cancer: a historical perspective.
Jeggo P, Pearl L, Carr A
Nat Rev Cancer. 2015; 16(1):35-42.
PMID: 26667849
DOI: 10.1038/nrc.2015.4.
Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.
Jiang D, Dumur C, Massey H, Ramakrishnan V, Subler M, Windle J
PLoS One. 2015; 10(2):e0118029.
PMID: 25695772
PMC: 4335025.
DOI: 10.1371/journal.pone.0118029.